My first thought is: oh, crap. This just to get WTO membership?
But if you read further into it, it begins to seem a little more complicated. For one thing, the already-approved generics can still be produced. There will be a new licensing fee, but it isn't specified how much that will come out to. So it's possible the price rise for India's generic AIDS drugs will be incremental rather than exponential; we'll have to wait and see.